Discover the complete record of transactions filed by Thakkar Roopal. Director active across 1 company, notably AbbVie Inc.. Aggregated, 13 reports have been published. History available since 15 February 2024. The latest transaction was filed on 27 February 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Thakkar Roopal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5,792 股0Common Stock, $0.01 par valueSEC:0001415889-24-004421:3
13 条申报中的 13 条
About Thakkar Roopal
Thakkar Roopal is a declarant linked to AbbVie Inc., where the company lists the role as EVP, R&D and CSO. The declarant has 13 filings in total, and the 13 sampled filings run from 2024-02-20 to 2026-03-03, with Attribution transactions and buy and sell amounts of 0 in this sample.